Stories similar to Systemic Sclerosis (Scleroderma) - Pipeline Review Market:

Pruritus - Pipeline Review Market 7 weeks 5 days ago

'Pruritus - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides A snapshot of the global therapeutic scenario for Pruritus. A review of the Pruritus products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

Pulmonary Arterial Hypertension - Pipeline Review Market 7 weeks 3 days ago

Scope

- A snapshot of the global therapeutic scenario for Pulmonary Arterial Hypertension.
- A review of the Pulmonary Arterial Hypertension products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

Chronic Cough - Pipeline Review Market 7 weeks 3 days ago

The Scope of the report is as follows :

- A snapshot of the global therapeutic scenario for Chronic Cough.
- A review of the Chronic Cough products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.

Infections Caused By Picornaviridae - Pipeline Review Market 7 weeks 1 day ago

The scope of the reports is as follows :

Scope

- A snapshot of the global therapeutic scenario for Infections Caused By Picornaviridae.
- A review of the Infections Caused By Picornaviridae products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. and many more......

Malignant Mesothelioma Pipeline Review 2 years 51 weeks ago

Malignant Mesothelioma - Pipeline Review, Q1 2011', provides an overview of the Malignant Mesothelioma therapeutic pipeline. This report provides information on the therapeutic development for Malignant Mesothelioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Malignant Mesothelioma.